“Bridging public-private sector efforts to address AMR have borne many fruits, with ShanX’s new testing device being one of our proudest collaborative achievements.” – AMR-Global
ShanX Medtech (SXM, NL) is honored to be recognized as a model of scientific and clinical collaboration in the fight against Antimicrobial Resistance (AMR). Our progress would not be possible without the steadfast support of our partners across the global health ecosystem.
Together, we are advancing a "Test Before Treat" future; one that prioritizes precision, speed, and shared impact.
Read more here: https://www.amr-global.org/news/shanx-medtech-ceo-sophia-shanko-envisions-a-test-before-treat-world
